First study to show that a genetic risk score remains an independent predictor of ischemic stroke in subjects who are older and have established cardiometabolic disease.
First study to show that lipidomic measurements can be used to achieve significant improvements in risk prediction of CAD in a large cohort with long-term follow-up
This study is the first clinical trial of an antisense drug CDR132L in HF patients.
The MR study indicate causal effects between TC, HDL-C and CKD. Decreased TC and elevated HDL-C may reduce the incidence of CKD but need to be further confirmed by using a genetic and environmental approach.
The study described that Lp(a) was the risk factor of CAHD in patients with LDL-C < 100 mg/dL. The correlation between Lp(a) and Gensini was influenced by LDL-C concentration, and the correlation was stronger than LDL-C when LDL-C < 104 mg/dL.
The study described the prevalence, characteristics, and outcomes of a new distinct electrocardiographic pattern of outflow tract ventricular arrhythmias (OTVA) with left bundle branch morphology and abrupt transition in lead V3 (ATV3) that localizes to the septal margin of the LV summit.